SCHEMBL25019995

SCHEMBL25019995

C/C=C/C1CCC[C@H]1COc1nc2c(c(N(CCC)CCC)n1)CCNC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22994708 0.64 HTR2A (0.34) —
SCHEMBL25021702 0.62 — —
SCHEMBL24730675 0.59 CHRNB4 (0.41) —
SCHEMBL24730879 0.58 CHRNB4 (0.38) —
SCHEMBL19637387 0.58 HTR2A (0.43) —
SCHEMBL25020839 0.57 CHRNB2 (0.43) —
SCHEMBL22360876 0.57 HTT (0.36) —
SCHEMBL22725374 0.57 KDM4E (0.30) —
SCHEMBL24731157 0.56 CHRNB4 (0.45) —
SCHEMBL24652491 0.56 CHRNB4 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710439-B1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2023-02-15 — — EP disclosed
Send feedback